Polyus PAO (PLZL)
Moscow Exchange · Russia · prices in RUB · close of 19 Oct 2026
Key indicators
| Last close | RUB 1,161.20 |
|---|---|
| 52-week range | 898.00 – 2,638.29 |
| Return, 1 month / 3 months | +21.5% / −8.6% |
| Return, 1 year / 3 years | −39.4% / +29.7% |
| Trend | Below its 200-day average |
| RSI (14) | 75 |
| Volatility (1 year) | 49.8% |
| Worst drawdown (1 year) | -64.0% |
| Average daily value traded | 3,799.19M RUB |
| Dividend yield | 10.5% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Polyus is a Russian gold mining company based in Moscow. It explores for, develops and operates gold deposits, mainly in Siberia and the Russian Far East, and produces gold doré and refined gold. Its mines include Olimpiada, Blagodatnoye and Natalka. The company sells gold to banks, refineries and other buyers in Russia and abroad, and it also produces related by-products such as antimony and silver.
On this site Polyus PAO appears as a stock on the Moscow Exchange (Russia), code PLZL, with prices in Russian rubles (RUB). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Polyus PAO (PLZL) trades on the Moscow Exchange in Russia. It last closed at RUB 1,161.20 on 19 October 2026.
Its price-based Market X-Ray is 25 out of 100 (a weak price profile), ranking 227 of 250 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 39.4% and over the last three months it fell 8.6%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Moscow Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 4 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -34.9% | ||
| From 52-week high | -55.6% | ||
| Momentum | 5 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -8.6% | ||
| 6-month return | -46.9% | ||
| 12-month return, skipping the last month | -50.1% | ||
| Stability (higher is calmer) | 14 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 49.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -64.0% | ||
| Liquidity | 97 · Strong | Trades actively. | |
| Average daily value traded | 3,799.19M RUB | ||
| Zero-volume days | 0.0% | ||
| Income | 47 · Weak | Dividend is small or irregular. | |
| Dividend yield | 10.5% | ||
| Years with dividends | 4 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | +9.3% |
|---|---|
| 1 month | +21.5% |
| 3 months | −8.6% |
| 6 months | −46.9% |
| 1 year | −39.4% |
| 3 years | +29.7% |
| 5 years | +9.5% |
Signals
| 50-day / 200-day average | 1,039.66 / 1,784.20 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 42.85 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 13 Jul 2026 | RUB 29.0500 |
| 18 May 2026 | RUB 56.8000 |
| 22 Dec 2025 | RUB 36.0000 |
| 13 Oct 2025 | RUB 70.8500 |
| 25 Apr 2025 | RUB 73.0000 |
| 13 Dec 2024 | RUB 1,301.7500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Moscow Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.